Risk factors for an adverse outcome in early invasive colorectal carcinoma.
By H. Ueno, H. Mochizuki, Y. Hashiguchi, H. Shimazaki, S. Aida, K. Hase, S. Matsukuma, T. Kanai, H. Kurihara, K. Ozawa and 2 more. Gastroenterology, 2004
749 citations recorded by the source corpus.
Subfields: Oncology, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/c7def5a9a6abe705119770d6db9be65d17819f91
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Pulmonary and Respiratory Medicine
Citations in the corpus
- Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer (2011, background): “[Definition of tumor budding] [79] A cancer cell nest consisting of 1 or less than 5 cells that infiltrates the interstitium at the invasive margin of the cancer.”
- Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer (2015, background): “1 3 (1) Depth of SM invasion ≥1000 μm (2) Vascular invasion positive (3) Poorly differentiated adenocarcinoma, signet-ring cell carcinoma, or mucinous carcinoma [126] (4) Grade 2/3 budding at the site of deepest invasion [126]”
- Colorectal polypectomy and endoscopic mucosal resection (EMR): European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline (2017, background): “The combined assessment of these features increases the accuracy of risk prediction [102, 225, 226] and allows the stratification of patients into low risk and high risk groups [102, 227, 228].”
- Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer (2019, background): “(1) T1b (depth of SM invasion ≥ 1000 μm) (2) Lymphovascular invasion positive (3) Poorly differentiated adenocarcinoma, signet‐ring cell carcinoma, or mucinous carcinoma [258] (4) Budding grade of BD2/3 at the site of deepest invasion [258]”
- Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer (2012, background): “[Definition of tumor budding] [136] A cancer cell nest consisting of one or fewer than five cells that infiltrates the interstitium at the invasive margin of the cancer.”